{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","description":"This cluster of papers focuses on the management of diabetes mellitus, with a particular emphasis on cardiovascular outcomes, glucose control, and the use of incretin hormones, SGLT2 inhibitors, and dipeptidyl peptidase-4 inhibitors. It also covers topics such as heart failure, glycemic control, insulin therapy, and clinical guidelines for the treatment of type 2 diabetes.","keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.4903},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.4984},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.2164},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.648},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.2924},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.5301},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.4422},{"id":"https://openalex.org/keywords/diabetes-treatment","display_name":"diabetes treatment","score":0.2571},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.2997},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.2494},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.461},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.4796},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.3585},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.419},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.5835},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.2287},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.2269},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.4457},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.5575},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.487},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.6737},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.4848},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.3795},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.5678},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.3331}],"legacy_keywords":"Type 2 Diabetes; Cardiovascular Outcomes; Glucose Control; Incretin Hormones; SGLT2 Inhibitors; Dipeptidyl Peptidase-4 Inhibitors; Heart Failure; Glycemic Control; Insulin Therapy; Clinical Guidelines","ids":{"openalex":"https://openalex.org/T10401","wikipedia":"https://en.wikipedia.org/wiki/Management_of_diabetes_mellitus"},"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"},"siblings":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins"},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments"},{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment"},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research"},{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments"},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors"},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education"},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments"},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies"},{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies"},{"id":"https://openalex.org/T11227","display_name":"Diabetic Foot Ulcer Assessment and Management"},{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients"},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension"},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders"},{"id":"https://openalex.org/T12964","display_name":"Diet, Metabolism, and Disease"},{"id":"https://openalex.org/T13453","display_name":"Alkaline Phosphatase Research Studies"},{"id":"https://openalex.org/T13966","display_name":"Neurological and metabolic disorders"}],"works_count":131602,"cited_by_count":1835307,"works_api_url":"https://api.openalex.org/works?filter=topics.id:T10401","updated_date":"2026-10-20T03:01:21","created_date":"2024-01-23T15:27:06"}